BCAT1 and melanoma: High expression of BCAT1 promotes gastric cancer, lung cancer, breast cancer, prostate cancer, glioma, hepatocellular carcinoma, urothelial cancer, melanoma, lymphoma, esophageal squamous cell carcinoma, head and neck squamous cell carcinoma, and nasopharyngeal carcinoma.